Psychiatry & Behavioral
Psychiatry
In the U.S., 20% of the population suffers from mental illness, creating a critical need for innovative treatments. CenExel is dedicated to partnering with sponsors to bring hope and relief to those in need — across pediatric, adolescent, adult, and senior populations.
Studies Conducted
0
+
Trial Participants
0
+
Active Centers
0
Overview
Leading Psychiatric Clinical Research
Complex psychiatric trials require specialized scientific and operational knowledge. CenExel's extensive team includes scientific, recruitment, rating, and operational experts — ensuring that your trials progress efficiently from first-patient-in to last-patient-out.
Our psychiatric clinical sciences team excels in designing first-in-human studies with unique biomarkers and critical endpoints. Expert raters and data monitors ensure high-quality efficacy and safety outcomes across even the most challenging protocols.
CenExel supports a wide range of conditions including mood disorders, anxiety disorders, behavioral disorders, combination disorders, and rare indications — across pediatric, adolescent, adult, and senior populations.
Conditions Covered
Psychiatric Conditions We Research
Our psychiatric research sites support a broad spectrum of conditions — from major depressive disorder and schizophrenia to rare and treatment-resistant indications.
Schizophrenia
Bipolar Disorder
Major Depressive Disorder (MDD)
Generalized Anxiety Disorder
Post-Traumatic Stress Disorder (PTSD)
ADHD (Adult & Pediatric)
Social Anxiety Disorder
Panic Disorder
Postpartum Depression (PPD)
Treatment-Resistant Depression
Schizophrenia – Pediatric
Bipolar Disorder – Pediatric
Our Approach
Why Sponsors Choose CenExel for Psychiatry
CenExel's psychiatric expertise goes beyond patient enrollment — we provide scientific consultation, rating integrity, and data quality that sponsors rely on for regulatory success.
01
Expert Rating Teams
Our expert raters and data monitors ensure high-quality efficacy and safety outcomes. Rating integrity is central to our psychiatric trial execution.
02
Biomarker Strategy
Our clinical sciences team designs first-in-human studies with unique biomarkers and critical endpoints — supporting go/no-go decisions earlier.
03
Diverse Populations
Access to diverse US metropolitan populations across 15 sites ensures your study reflects real-world patient demographics.
04
100%+ Enrollment
CenExel's in-house recruitment team consistently exceeds 100% of patient enrollment targets through precision targeting and culturally resonant messaging.
Phase Coverage
Supported Trial Phases
CenExel supports early and late phase psychiatric research — from first-in-human proof-of-concept studies through Phase IV post-market trials.
Active across all phases
Phase I
Phase II
Phase III
Phase IV
Our early phase capabilities include pharmacodynamic biomarker strategies, first-in-human studies, and proof-of-concept trial design — guided by Chief Scientific Officer Dr. Larry Ereshefsky, an internationally recognized KOL in CNS research with over 30 years of early phase expertise.
Psychiatry Task Force
CenExel supports a wide range of conditions including mood disorders, anxiety disorders, behavioral disorders, combination disorders, and rare indications — across pediatric, adolescent, adult, and senior populations.
Explore Our Network
Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.
View More
Therapeutic Area
Women’s Health
Women’s health is essential across every stage of life. CenExel is dedicated to advancing clinical research in women’s health
Therapeutic Area
Acute Pain & Post-Operative
Post-operative pain remains a critical challenge in surgical recovery, impacting patient outcomes and satisfaction.
Therapeutic Area
Allergy & Immunology
Advancing clinical research for allergic, immunologic, and inflammatory conditions through experienced investigators,